Corrigendum to "Immune-checkpoint inhibition in first-line treatment of advanced non-small cell lung cancer patients: Current status and future approaches" [Lung Cancer 106 (2017) 70–75]. (March 2018) - Remon, J.; Pardo, N.; Martinez-Martí, A.; Cedrés, S.; Navarro, A.; Martinez de Castro, A.M.; Felip, E.